Head-to-head · WeighScore
Oak vs WeightRx
The verdict
WeightRx takes it — 72.1/100 to 63.2/100.
WeightRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. WeightRx is a telehealth provider publishing compounded semaglutide at $250/mo and compounded tirzepatide at $83/mo.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Oak | WeightRx |
|---|---|---|
| WeighScore | 63.2/100 | 72.1/100 |
| Grade | C | C |
| Scorecard rank | #217 | #97 |
| Semaglutide | $250/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $200/mo that morning | $250/mo (compounded) |
| Tirzepatide | $300/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $250/mo that morning | $83/mo (term not published, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #217 · C
Strengths
- No membership or subscription fee, and free shipping
- All 50 states, offered in Spanish as well as English
- One price at every dose, so titrating up does not cost more — its order form states it as "One price · All dosages" beside the figure itself
- The price is reachable without handing over any medical detail: the figures sit on the first screen of its order form, before a single question is answered
Where it loses points
- Its advertising and its order form disagree: none of the nine "starting" figures it markets is the $200/$250 it actually charges, so anyone comparing on the advertised numbers is comparing against a price Oak does not offer
- Nine conflicting "starting" figures appear across Oak's own pages — $119, $133, $160, $167, $180, $185, $190, $199 and $250 — and none carries a term or a billing cadence. Its headline "$133 / $199" is the three-month prepay under code OAKSAVE200, billed upfront, not a monthly rate
- The cheapest two, "$119" and "$185", sit beside a "$200 off" new-patient offer that Oak elsewhere describes as "$50 off your first month, $200 off 3-months" — a three-month package discount, not a monthly rate
- Its two comparison tables disagree with each other and with its two FAQs: $167/mo against $190/mo, "as little as $119/month" against "as little as $190/month or lower"
- Worth re-checking at the last step: an earlier reading of its checkout copy recorded dose steps costing roughly $50–$75 more, which its order form's "One price · All dosages" line contradicts
- Same-day approval with no video call means very little clinical contact before a prescription
- No published lab or monitoring program
- Injection only, and no brand-name lane
- Sold as packages, so re-ordering is on you
Graded #97 · C
Strengths
- The tirzepatide figure is published up front, and it is genuinely low against the field
- Both molecules are offered
- No membership charge is advertised alongside the medication rate
Where it loses points
- The $83 monthly rate is advertised as '$83/month ($997/year)', which is twelve months of it — no month-to-month rate is separately published, and the terms state that a rate is locked for its full term
- Both product pages linked from the homepage return 404, so the plan terms cannot be read before intake
- Six- and twelve-month plans are non-refundable, and eligible refunds carry a 5% processing fee
- No dose strength is published anywhere, so what the $83 buys is not stated
- The named operator is Twist G Marketing, LLC rather than a clinical entity, and the terms carry a binding arbitration and class-action waiver
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.